Sunteți pe pagina 1din 44

2/10/2015

CHEM3407/3410 & BPHM3015

Medicinal Chemistry

Nucleic acid as a drug target


Hongzhe SUN
Chemistry & Pharmacy
HKU
2nd Semester, 2015

Medicinal Chemistry

Nucleic acids as drug targets

NH2

Cytosine
(C)

BASES

3N

N
1
9

3 NH

5 3
1

Pyrimidine

7
9
N
H

Adenine
(A)

1
3

Purine

1N

3 NH

DNA
1

Uracil (U)

RNA

Thymine
(T)

Nitrogen-containing ring
Hetero-cyclic AMINES

H 3C

NH2

NH2

Guanine (G)

2/10/2015

7. NUCLEIC ACIDS AS DRUG TARGETS


Contents
7.1. Deoxyribonucleic Acid (DNA)
7.2. Ribonucleic Acid (RNA)
2.1. Primary & Secondary structure
2.2. Tertiary structure
2.3. Transcription
2.4. Translation - protein synthesis
7.3 Genetic Engineering
3.1 DNA Recombinant Technology
3.2 Amplification of a gene

7.4. Drugs Acting on DNA or RNA

Where is DNA found


In the cell lies the nucleus which
house the chromosomes.
Cells

Nucleus

Chromosome: For
human beings there are
22 pair of chromosomes
which determines traits
with 23rd pair
determining sex. XX female and XY - males.
Some individuals have
three or have YX
chromosomes

Genes: One-gene-oneenzyme hypothesis


Deoxyribose nucleic acid: DNA- Deoxyribose nucleic acid
houses the gene which codes for the protein which makes
each life from including you and me.
1

2/10/2015

Tidbits on DNA
DNA is responsible for all
the proteins in us.
We share 98 % of the same
genes as chimps

All the DNA in your body


unwound would stretch to
the Sun and back.
1

Nucleic Acids in Virus, Bacteria and Human Cells

bacteria

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.1 Primary Structure
Nucleotide = Phosphate + Sugar + Base
O

NH2
N1

NH2

Base

5 7
4 9

HN1
8

5 7
4 9

H2N

N
H

N
H

Guanine

Adenine

HO3PO
O

Phosphate

Purines

H
H

Sugar

H
HO

NH2

N3
2

Deoxyadenosine
phosphate

HN3

Cytosine

2 1

N
H

CH3

N
H

Thymine

Pyrimidines

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.1 Primary Structure
NH2

5' end
N
O
O P O
OH

5'

CH2

H
H

1'

3' H H
O CH2

OH

Cytosine (C)
O

O
N

NH

N
P

OH
H

Base

O
O P O

OH

N
N

Base

O P O

NH2

O
O

5' end

Adenine (A)

O CH2

OH

Base
O

OH
H

Me

NH

O
N
P

O
O P O

Guanine (G)

NH2

O CH2

OH

Thymine (T)

3' H

Base
O

OH

O
O P O

3' End

3' End

1. Sugar phosphate backbone is invariant, bases attached in random order


2. The order of bases provides the primary structure of DNA
3. Nucleic acids are named in the 5 3 direction (No 5-5 or 3-3 linkages)

2/10/2015

Comparison of nucleic acids and proteins


5

Protein

Phosphate
Sugar C
5-end dpCpApT 3-end
Phosphate
d(pCAT)
Sugar A
Phosphate
Sugar T
3
Nucleic acid

Q. Any possibility to have a biopolymer with protein backbone as the


backbone and nucleic bases as the side-chain?

The peptide nucleic acids (PNAs) constitute a remarkable new class of synthetic nucleic
acid analogues, based on their peptide-like backbone. This structure gives to PNAs the
capacity to hybridize with high affinity and specificity to complementary RNA and DNA
sequences and a great resistance to nucleases and proteinases.
3-end
N-terminus

C-terminus

Protein

PNA

DNA
1

5-end

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.2 Secondary Structure - Double Helix
o
10A
G

A T

Major
groove

TA
T A
G

C
G

TA
T
T
Minor
groove

A T
A T
T A
C G
G

o
34A
C

TA
G

T
C

G C

GC
T A
A

Sugar phosphate backbone is ionised


and faces outward (favourable
interactions with water)
Nucleic acid bases point inward and
pair up A-T or G-C
Purine pairs with pyrimidine constant diameter to helix
Base bairs are stacked (vdw
interactions between pairs)
Chains are complementary

TA
T

DNA DOUBLE HELIX

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.2 Secondary Structure - Double Helix
10
G

Thymine

Me

A T

Major
groove

TA
T A
G

C
G

O P
O

C
TA

O
o
34A

5'

T
C

G
TA

DNA DOUBLE HELIX

O
5'

N
NH2
N

3'

O
O

N
N

HN

3'

O
P

N
O

O
O

3'

G C
GC
T A
A

C
TA

3'

A T
T A
C G
G

NH

O
O

5'

A T

O
N

T
Minor
groove

Adenine
H2N

Cytosine

H2N

Guanine

5'

O
O

O
P

Base Pairing
G-C base pairing involves 3 H-bonds
A-T base pairing involves 2 H-bonds
1

2/10/2015

Effect of base-pair composition on the denaturation


temperature of DNA
10
Too wide
Too narrow

Q: AT-rich regions melt more easily than GC-rich regions?

1. DNA Replication
New
DNA
chains
Template

DNA
Double Helix

New
DNA
chains

Template

Replication

DNA
Daughter helices
1

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.2 Secondary Structure - Double Helix
Replication

Approach of trinucleotide

Base pairing

Enzyme-catalysed 'splicing'

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.3 Tertiary Structure

Double helix coils into a 3D shape - supercoiling


http://www.youtube.com/watch?v=EYGrElVyHnU&feature=related

(other one is ok)

Double helix has to unravel during replication

Unravelling leads to strain

Relieved by enzyme catalysed cutting and repair of DNA


chain

Important to the activity of the quinolone and fluoroquinolone


antibacterial agents which act as Topoisomerase enzyme
inhibitors
1

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.4 Action of topoisomerase II
Relieves the strain in the DNA helix by temporarily cleaving the DNA
chain and crossing an intact strand through the broken strand

Topo II

Tyr

5'
3'

3'

DNA

5'

Tyrosine residues in the enzyme are involved in the chain breaking process
The residues form covalent bonds to DNA

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.4 Action of topoisomerase II
Relieves the strain in the DNA helix by temporarily cleaving the DNA
chain and crossing an intact strand through the broken strand

Topo II

Tyr
5'

3'

3'

Tyr

DNA

5'

Topo II

Tyrosine residues in the enzyme are involved in the chain breaking process
The residues form covalent bonds to DNA
The enzyme pulls the chains apart to create a gap

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.4 Action of topoisomerase II
Relieves the strain in the DNA helix by temporarily cleaving the DNA
chain and crossing an intact strand through the broken strand

Topo II

Tyr
Tyr

DNA

Topo II

Tyrosine residues in the enzyme are involved in the chain breaking process
The residues form covalent bonds to DNA
The enzyme pulls the chains apart to create a gap
The intact strand of DNA is passed through the gap

10

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.4 Action of topoisomerase II
Relieves the strain in the DNA helix by temporarily cleaving the DNA
chain and crossing an intact strand through the broken strand
3

Topo II

Tyr
5'

3'

3'

5'

Tyr
Topo II

Tyrosine residues in the enzyme are involved in the chain breaking process
The residues form covalent bonds to DNA
The enzyme pulls the chains apart to create a gap
The intact strand of DNA is passed through the gap
The break is resealed
1

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.4 Action of topoisomerase II
Relieves the strain in the DNA helix by temporarily cleaving the DNA
chain and crossing an intact strand through the broken strand
4

Topo II

Tyr
5'

3'

3'

5'

Tyrosine residues in the enzyme are involved in the chain breaking process
The residues form covalent bonds to DNA
The enzyme pulls the chains apart to create a gap
The intact strand of DNA is passed through the gap
The break is resealed
1

11

2/10/2015

7.1. DEOXYRIBONUCLEIC ACID (DNA)


1.4 Action of topoisomerase II
Mechanism of chain cutting
5'

5'
H

Base

O
H

HO

O
O P
O O

HO

Tyr

O P
O O

TopoII

Base

O
H

Tyr

Base

O
H

TopoII

Base

O
H

3'

3'

7.2. RIBONUCLEIC ACID (RNA)


2.1 Primary & Secondary Structure of RNA
Similar to DNA with the following exceptions

Ribose is used instead of deoxyribose

Uracil (U) is used rather than thymine (T)


O
HOCH2 O
H

OH

HN

H
OH

OH

Ribose

N
H

Uracil

Single stranded

Some regions of helical secondary structure exist due to base


pairing within the same strand (see t-RNA)

Adenine pairs to uracil (A-U); guanine pairs to cytosine (C-G)


1

12

2/10/2015

7.2. RIBONUCLEIC ACID (RNA)


2.2 Tertiary structure
There are three type of RNA nucleic acids. They serve different
purpose.
1. Messenger RNA (mRNA):

carries the genetic info from the DNA in


the nucleus to cytoplasm
not very stable & synthesized as needed
2. Ribosomal RNA (rRNA):

This is where protein synthesis occurs also


known as the protein factory.
found in the ribosomes
small spherical bodies in the cells but outside the nuclei
large molecules
3. Transfer RNA (tRNA):

Smallest of RNA, is responsible for carrying amino acids to the


protein factory (r-RNA) and coordinating the amino acid
1
monomeric unit to make a protein..

7.2. RIBONUCLEIC ACID (mRNA)


2.3 Transcription
The copying of a segment of DNA which codes for a specific protein

G
U
A
U
C
U
G
U
C
C
C
U
U
A

mRNA
G
T
A
T
C
T
G
T
C
C
C
T
T
A

DNA double helix

C
A
T
A
G
A
C
A
G
G
G
A
A
T

DNA unravelled
to reveal gene

G
T
A
T
C
T
G
T
C
C
C
T
T
A

G
U
A
U
C
U
G
U
C
C
C
U
U
A

C
A
T
A
G
A
C
A
G
G
G
A
A
T

mRNA

Transcription

13

2/10/2015

7.2. RIBONUCLEIC ACID (tRNA)

Base Pairing

3'p
end
A
AMINO
ACID
C
C
5'p
end A
G
C
G
C
G
U
C
G
G
C
U
U
A
U
U UA
G
G
C
G
A G G C C
UH2
C G C G mGU
G
C
U C C G G
G
C
T PsC
A G C G C m2G
G UH2
C
G A UH2
G
U
A
C
G
C
G
C
G
Ps
U
U
mI
I
C
G

Yeast alanine-tRNA

mI Methylinosine
I
Inosine
UH2 Dihydrouridine
T
Ribothymidine
Ps
Pseudouridine
mG Methylguanosine
m2G Dimethylguanosine

ANTICODON

Amino
acid

t-RNA

AC G
Anticodon
binding region
for m-RNA

Anticodon - the 3 bases are specific for the attached amino acid
Condon - base pair to the complementary triplet code on
m-RNA
1

7.2. RIBONUCLEIC ACID (RNA)


2.4 Translation - protein synthesis
His
Growing
protein chain

Ribosome

His

Peptide
transfer

60S

mRNA

OH

His

GCA

P-site A-site
GCU
CGA CAU GUC

mRNA

GCU GUA
CGA CAU GUC

mRNA

GCU GUA
CGACAUGUC

40S

14

2/10/2015

2. RIBONUCLEIC ACID (RNA)


2.4 Translation - protein synthesis
Val

OH

tRNA

OH

His

CAG

His

His

GCU

Translocation

mRNA

GCU GUA
CGACAUGUC

P-site
mRNA

GUA
CGA CAU GUC

mRNA

A-site
GUA
CGA CAU GUC

7.2. RIBONUCLEIC ACID (RNA)


2.4 Translation - protein synthesis
PEPTIDE
NH2

NH

R' C H
O C

R C H
O C
HO
H
H
Adenine

HO
H
H

O
H
O

H
O

OH
P O

Adenine

O
H
O

H
O

OH

O
t RNA

t RNA

Transfer of
growing peptide
chain to next
amino acid

PEPTIDE

P O
O

NH
R C H
O C
NH

HO
H
H
Adenine

R' C H
O C

OH
H
O

H
OH
O

P O
O

HO
H
H
Adenine

O
H
O

t RNA

H
OH
O

P O
O

t RNA

15

2/10/2015

7.2. RIBONUCLEIC ACID (RNA)


2.4 Translation - protein synthesis
Overview

mRNA
Ribosome

Amino acid

DNA

tRNA

mRNA
Translation

Transcription
Nucleus

Protein

7.3. GENETIC ENGINEERING


Introduction
(general definition): direct human manipulation of an organism's
genetic material in a way that does not occur under natural conditions
- select, isolate and copy genetic material of interest to make a construct
- introduce this construct to plasmid (circular form of DNA) of host
(bacteria or yeast or animal cell), either indirectly via a viral vector or
directly through injection techniques or physical stimulations
- wait the modified plasmid to be expressed within the host to give
genetically modified DNA or protein, then kill the host to release the
as-synthesized DNA or protein product, finally purified them by using
SDS-PAGE and affinity chromatography (~1-5 mg product / kg of host)
1

16

2/10/2015

7.3. GENETIC ENGINEERING


3.1 Recombinant DNA technology
'Sticky' ends
GAATAC
C TTAAG

DNA
GAATAC
C TTAAG

Restriction
enzyme
Restriction
enzyme

G
C TTAA

G
C TTAA

AATAC
G

Annealing

GAATAC
C TTAAG

+
G AATAC
C TTAAG

AATAC
G

DNA ligase
enzyme

DNA

GAATAC
C TTAAG

isolate either one

+
G AATAC
C TTAAG

Notes:
Restriction enzymes split DNA strands at specific base pair regions
The DNA strands are split unevenly with sticky ends which allow
annealing
Ligase enzymes repair the chains
1

7.3. GENETIC ENGINEERING


3.1 Recombinant DNA technology
- Segments can be added to both ends of a DNA fragment in
order to make the DNA recognisable to restriction enzymes

DNA fragment
or vector

Ligase
CCGAAT TCGG
G C C T T AAGC C

CCGAATTCGG
G C C T T AAGC C

Synthetic linker
AATTCGG
GCC

DNA fragment
or vector

CCGAAT TCGG
GC C T T AAG C C

Restriction
enzyme
CCG
DNA fragment
G C C T TAA
or vector

construct

17

2/10/2015

7.3. GENETIC ENGINEERING


3.2 Amplification of a gene
or construct

Plasmid split

a) Human
DNA

Restriction
enzyme

b) Ligase
Vector DNA
= plasmid
introduce back to the bacteria host
(injection or physical stimulation)

DNA/protein synthesis

gene expression

Notes:
Plasmids are circular segments of DNA transferred between bacterial cells
A gene can be inserted into a plasmid
Plasmids are introduced to bacterial cells and multiple copies are
synthesised
1

7.3. GENETIC ENGINEERING


3.2 Amplification of a gene
Gene
Phage

E. coli

Gene

E. coli

E. coli

Notes
Gene can be inserted into a bacteriophage
Bacteriophages are viruses which infect bacterial cells
Multiple copies of the bacteriophages are produced along with the gene

18

2/10/2015

7.3. GENETIC ENGINEERING


Applications
mass production of insulin,
recombinant human growth
hormone (rHGH)

G-quadruplex DNA:
In addition to the familiar duplex DNA, certain DNA sequences can fold into
2nd-structures that are four-stranded;
they are made up of guanine (G) bases, such structures are called Gquadruplexes.
these structures may exist in vivo in specific regions of the genome including the
telomeric ends of chromosomes and oncogene regulatory regions.
(Trends Pharmacol Sci. 2000 21, 136)

9
7
3

7
9

1
3

19

2/10/2015

Two or more G-rich


repeats can form GG
hairpins, which in turn
dimerize to form
several types of stable
bimolecular
quadruplexes,
A tetramolecular parallel Gquadruplex from four DNA
strands each with a single
G-rich repeat.

Long G tracts can fold upon


themselves to form an
antiparallel intramolecular
quadruplex, termed an
intramolecular foldover Gquadruplex.

Structure of G-quadruplex d(GGGGTTTGGGG)

N+
H

N+
H
O
HN

O
H+
N

NH

PDBID: 1L1H
Ligand:3,6-bis-[3-pyrrolidino-propionamide] acridine (BSU6039)
Metal: K+ (Haider SM et al J. Mol. Biol. 2003, 326:117)

20

2/10/2015

7.4. DRUGS ACTING ON DNA

Intercalating agents
Alkylating agents
Metallating agents
Chain cutters
Chain terminators

Selected examples of RNA base methylation

(Chuan, Nat. Chem. Biol. 2010, 6:863-865)


1

21

2/10/2015

7.4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Mechanism of action

Contain planar aromatic or heteroaromatic ring systems

Planar systems slip between the layers of nucleic acid pairs


and disrupt the shape of the helix

Preference is often shown for the minor or major groove

Intercalation causes the DNA replication machinery to skip


or insert additional nucleotides at the intercalated site
DNA, preventing DNA replication and transcription

Intercalation inhibits topoisomerase II

4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Example - Proflavine

H2N

NH2

Proflavine

Planar tricyclic system


The amino substituents are protonated and charged
Used as an antibacterial agent in the WWII
Targets bacterial DNA
DNA breaks
stop cell cycle progression

apoptosis
1

22

2/10/2015

4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Example - Proflavine

not only ONE intercalator


per one DNA, everywhere!

Proflavine
G C
AT
TA
T A
G C
G C

H 3N

NH3

sugar phosphate
backbone

TA
T A
T A
AT
AT
T A
C

T
G
G C

H 3N

TA
T A

proflavine

NH3

G C
GC
GC
T A
A T
C G

TA
T A

DNA double helix

van der Waals interactions


Ionic interactions

transcription or replication

Proflavine

topoisomerase II
2KD4

cell death
1

23

2/10/2015

4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Examples- antimalarial agents
H

CH3
H

NH CH

HO

CH2CH3
(CH2)3 N

CH2CH3

MeO

Cl

Chloroquine

Quinine

pathogenic mosquitos parasite


Plasmodium falciparum
1

4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Examples Antibiotics with anticancer activity
N-Me-Gly

N-Me-Gly
L-Pro

N-Me-L-Val

D-Val

O
H

N-Me-L-Val

C
Me

C
C

C
Me

NH
C

C
C

CH2OH
OH

NH

OMe

OH H

NH2

O
CH3

OH

D-Val

O
O

L-Pro

O
CH3

Dactinomycin

Extra binding to sugar phosphate


backbone by cyclic peptide

HO

Me
H
NH3

Doxorubicin (Adriamycin)

Extra binding to sugar


phosphate backboneby
1 NH3

24

2/10/2015

4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Notes on dactinomycin
Intercalates via minor groove of DNA double helix
Prevents unwinding of DNA double helix (disables replication)
Blocks transcription by blocking DNA-dependent RNA
polymerase
Notes on doxorubicin (or adriamycin)
Intercalates via the major groove of DNA double helix
Blocks the action of topoisomerase II by stabilising the
DNA-enzyme complex (prevents the resealing of DNA double helix)
Acts as a topoisomerase poison

7.4. DRUGS ACTING ON DNA


4.1 Intercalating agents
Examples - Bleomycins
CONH2
H
N
H

primary amine
NH2
H
NH
O

pyrimidine N
ring

Me
H
O

H H H
N

HO

NH

HO

HN

O
N
H
N

OH

H
O

OH

O
Me

H2N

primary amine

O
2

primary amide

NH

Me

HO

Me

Bithiazole
intercalating
region

imidazole
ring

Bleomycin A2
Bleomycin B2

R = NHCH2CH2CH2SMe2
R = NHCH2CH2CH2CH2NHC(NH2)=NH

OH
OH
O

OH

NH2

25

2/10/2015

Bleomycin
A natural product and is isolated from
the Streptomyces. It can both complex a
metal centre and interact with DNA.
Small molecule-metal ion complexes that
can produce radical species capable of
cleaving DNA are known.
In the presence of Fe(II) and dioxygen or
Fe(III) and hydrogen peroxide bleomycin
can induce cleavage in both single and
double stranded DNA.
metal is bound to the
peptide section of the molecule.

How does it cleave DNA?


A ferric peroxide or possibly a high valent Fe(V)-oxo
species is formed that abstracts hydrogen atoms from
the deoxyribose rings of DNA.
The subsequent ring opening steps have been well
characterized with two pathways possible- dependent
on whether or not there is more oxygen present.
Clinical application
The first antibiotics active against cancer were discovered in the 1950s and
bleomycin was one that was later screened in response to the nephrotoxicity of
the other antibiotics already tested.
Clinical trials were effective and it was introduced commercially in 1969. It is
used against a variety of cancers.

26

2/10/2015

O2 molecule
ROS
O2 radical anion
HOO free hydroxy radical
O2- superoxide

Abstract H radical from


DNA (damage)

cell death

Tutorial1: Bisanthracycline WP631, is an antibiotic targeting on DNA.


Whats its potential binding mode? Check PDB: 1al9
O

OH

OH

OH
O

OH

H2N

H 2N
HO
O
O

OH

OH

OH

27

2/10/2015

Tutorial2: Analyze the binding of the following drugs targeting on


DNA.

Groove binding:
Groove binding: direct interaction of the bound molecule with the
edge base-pairs in either of the groove of the nucleic acids
5'-d(CGCAAATTTGCG)-3') complex with netropsin (PDB: 1dne)
+
N 9H 2
O

H2N10
N8
H
H

N7

CH3

H
HN6
H

O
N5 CH3

HN4

netropsin

O
H2N2

HN3
N 1H 2
+

28

2/10/2015

H
N

2
3
4
5

6
7
8
9
10
11
12

324

CG
GC 23
CG 22
AT 21
AT 20
AT 19
TA 18
TA 17
TA 16
GC 15
CG 14
GC 13

O
H

H3C

+
N 9H 2
O

H2N10
N8
H
H

N
N7

CH3

C'

HN6
H

'C

H
O
N5 CH3

HN4

H
O

H2N2

HN3

8.6

N 1H 2
+

netropsin

7.4

Major
groove

Deformation

4. DRUGS ACTING ON DNA


4.2 Alkylating agents
(1o carbocation)
Notes
Contain highly electrophilic groups RX R+ + X Form covalent bonds to nucleophilic groups in DNA
(e.g. 7-N of guanine)
Prevent replication and transcription
Useful anticancer agents
Toxic side effects (e.g. alkylation of proteins)
Can cause interstrand and intrastrand cross-linking if two
electrophilic groups present
normally, formation of N-alkylated DNA adduct always
compensate the energy loss due to disruption of double helix
structure maintained by intermolecular H-bonds between BPs
Alkylation of nucleic acid bases can result in miscoding
1

29

2/10/2015

Which one can be readily N-alkylated?


COOH3 N+

COOH3 N+

CH2

CH2

CH2

CH2

CH2

CH2

CH2

NH

NH3+

COO-

COOH3N+

H3N+

CH2

CH2
+

HN
+

HN

NH
NH2+

NH2

Discussion: Methylayion of nucleic acids

4. DRUGS ACTING ON DNA


4.2 Alkylating agents
Cross linking

Nu

Nu
Nu

Nu

Nu

Intrastrand cross linking

Nu

Nu

Nu

Interstrand cross linking

30

2/10/2015

4. DRUGS ACTING ON DNA


4.2 Alkylating agents
Nucleophilic groups on nucleic acid bases

nucleophilic
groups

NH2

NH2
7

nucleophilic
groups

N
3

HN
H2N

N
R

R
Adenine

Cytosine

Guanine

4. DRUGS ACTING ON DNA


4.2 Alkylating agents

Miscoding resulting from


alkylated nucleic acid bases

Normal base pairing

Thymine

Cytosine

NH2
N

DRUG

Me

Abnormal base pairing.


Alkylated guanine prefers
enol tautomer

Guanine prefers
keto tautomer
Thymine
Me

Adenine
H2N

O P

O
O P
O

NH

O
O

5'

N
N

3'

3'

stronger H-bond between


NH3+ and C=O

O
5'

from A-T to A-C pair?

H2N

H2N

How about the


N-alkylated adenine?

NH

N
N

HO

HN

N
R

Alkylated guanine

Guanine

O
P

31

2/10/2015

7.4. DRUGS ACTING ON DNA


4.2 Alkylating agents
Example
Chlormethine (nitrogen mustard)
Cl
CH3

N
Cl

Notes
Used medicinally in 1942
Causes intrastrand and interstrand cross-linking
Prevents replication
Mono-alkylation of guanine also possible
Analogues with better properties have been prepared

4. DRUGS ACTING ON DNA


4.2 Alkylating agents
Mechanism of action

some bond length not in scale


DNA

DNA
O

G = Guanine

H
N

NH2

Cl
CH3

CH3

H
N

CH3

G
Cl

NH2
N

N
N

Cl

Aziridine ion

Mechlorethamine

Cl
N

N
NH

NH2

DNA

DNA

NH2

interstrand

NH2
N

Crosslinked DNA

CH3

H
N

H
N

NH2
NH

NH2
NH

N
O

CH3

NH2
NH

32

2/10/2015

4. DRUGS ACTING ON DNA


urea

4.2 Alkylating agents


Example - Nitrosoureas
O

Cl

Cl
N
O

Nitroso

NH2-(C=O)-NH2

Cl

N
H

Lomustine

N
H

Nitrosyl in OM

N
Carmustine

Mechanism
Decompose in body to form an alkylating agent and a
carbamoylating agent
O C N R
Isocyanate
(carbamoylating
agent)
+

O
Cl

R
N

N2 + HO

Cl
N

Cl

Alkylating
agent

OH

or other Nu:

7.4. DRUGS ACTING ON DNA


4.2 Alkylating agents
Example - Nitrosoureas
Cl
Cl

DNA

Alkylating
agent
DNA

DNA

Protein-Lys-NH 2
O C N R
Isocyanate

Crosslinking

Alkylation

Protein-Lys-NH
Carbamoylation

HN

Notes
Alkylating agent causes interstrand cross-linking
Cross linking between G-G or G-C
Carbamoylating agent reacts with lysine residues on proteins
May inactivate DNA repair enzymes
1

33

2/10/2015

7.4. DRUGS ACTING ON DNA


4.2 Alkylating agents
O
O
S
Me

Busulfan

Me

S
O
O

Synthetic agent used as anticancer agent


Causes inter-strand cross-linking

Mechanism
O
O
S
Me

O
O

OSO2Me

Me
S
O
O

Guanine
H2N

HN
N

-MeSO3-

N
DNA

DNA

DNA

-MeSO3-

DNA

methane sulfonate anion stable!

DNA

7.4. DRUGS ACTING ON DNA


4.2 Alkylating agents
Example - Mitomycin C
urethane
O

1o amine

CH2OCONH2

H 2N

OMe
N

Me
O

NH

Aziridine ring

quinone ring
Notes
Prodrug activated in the body to form an alkylating agent
One of the most toxic anticancer drugs in clinical use
1

34

2/10/2015

Mechanism
O

H
OH

CH2OCONH2

H 2N

OMe
N

Me

Enzyme

H 2N

Reduction Me

NH

-MeOH

NH

Ring
opening

H2N-DNA

H2 N-DNA
NH-DNA

N
NH2

OH

Alkylating agent

NH

OH

CH2

CH2

H2N

H2N

NH

NH-DNA
NH2

OH

N
N

O Guanine
N
HN
N

Me

Me

O Guanine
HN

NH-DNA

OH

CH2

H2N

Me

NH2

OH

-CO2
-NH3

NH2

O
OH

CH2OCONH 2

Me

H2N

NH

OH

hydroquinone

-H +

Me

OH

quinone ring

CH2OCONH 2

H2N

OMe

CH2OCONH2

NH2

OH

1
Interstrand crossed-linked DNA

4. DRUGS ACTING ON DNA

Cl

4.3 Metallating agents

Cl

NH3

Cisplatin

Pt
NH3

Neutral inactive molecule acting as a prodrug


Platinum covalently linked to chloro substituents
Ammonia molecules act as ligands
Activated in cells with low chloride ion concentration
Chloro substituents replaced with (by) neutral water ligands
Produces positively charged species
Cl

NH3
Pt

Cl

H2O

NH3 +

H2O
Pt

NH3

Cl

NH3

H2O
+

NH3
Pt

H2O

NH3

2+

DNA

DNA

NH3
Pt

DNA

NH3

Cisplatin

Prodrug

Drug

Platination
1

35

2/10/2015

7.4. DRUGS ACTING ON DNA


4.3 Metallating agents
Binds to DNA in regions rich in guanine
units
Intrastrand links rather than
interstrand
Localised unwinding of DNA double
helix
Inhibits transcription

N7

Pt

N7

Discuss in details later!


DNA-repair fails! (shielded by HMG binding)
http://www.youtube.com/watch?v=Wq_up2uQRDo&NR=1
1

4. DRUGS ACTING ON DNA


4.4 Chain cutters
trisulfide chain
HO
CH3

O
H3C

OMe

H3C

NHCO2Me

S
S
H3C

O N
HHO

OH

Calicheamicin g1
Antitumour agent

O
O

OMe
H3C
HO
MeO

O
OH

H3C

H
N
MeO

enediyne
system

Generates DNA diradical


DNA diradical reacts with oxygen
Results in chain cutting (prevent DNA ligase from repairing the damage)

36

2/10/2015

4. DRUGS ACTING ON DNA


4.4 Chain cutters
Mechanism
H

HO

NHCO2Me
S
S

HO

- Nu-S-SMe

HO

Michael
addition

NHCO2Me

H
NHCO2Me

MeS
Nu

Cycloaromatisation

HO

HO

NHCO2Me
H

NHCO2Me
DNA

DNA
(Diradical)

O2

R
H

Oxidative
cleavage

(formation of
benzene ring)

Oxidative Cleavage of DNA by OH radicals (sugar)


abstraction of one H of deoxyribose initiates

two chains break away


base
O

O
N

HN

H
H 2N

N
dR

Guanine (lower oxidation potential)

HN

+ OH

OH
H 2N

N
dR

8-hydroxyguanosine

37

2/10/2015

Oxidative Damage of DNA by OH radicals (base)

tautomerize

free bond rotation

cell death or
induce mutation?

1
miscoded G-A base
pairing

7.4. DRUGS ACTING ON DNA


4.5 Chain terminators
Basic requirements
- must be recognized by the bases in the DNA template
- must have triphosphate group so that they can undergo the same
enzyme-catalysed reaction as the normal substrate does
- must contain non-hydroxy group so that addition of new nucleotide
to the growing DNA chain is not achievable

Mimicking nucleotide !

38

2/10/2015

7.4. DRUGS ACTING ON DNA


4.5 Chain terminators

False substrate (nucleotide)

Thymine (T)
Azidothymidine (AZT)
(Zidovudine;Retrovir)

O
HN
O

HO P O P O P O
HO

CH3

HN

CH3

OH

OH

N
O

OH
N3

N3

dR mimick
(functionalised)

Chain terminating
group

Notes:
Azidothymidine is a prodrug used in the treatment of HIV
AZT is phosphorylated to a triphosphate in the body
Triphosphate has two mechanisms of action
- inhibits a viral enzyme (reverse transcriptase)
- is added to growing DNA chain and acts as chain terminator

Glossary
Prodrug a molecule that is inactive in itself, but which is
converted to the active drug in the body, normally by an
enzymatic reaction.
The purpose of using it is to avoid problems related to the
pharmacokinetics of the active drug and for targeting. (discuss in
next section!)

39

2/10/2015

7.4. DRUGS ACTING ON DNA

2-aminopurine
(not 6-aminopurine (A))

4.5 Chain terminators


Guanine(G)

O
HN
H2 N

Aciclovir
(Zovirax)

AcO

N
O

HO

Chain
terminating
group

OAc

Famciclovir
(Famvir)

N
N

NH2

Chain
terminating
group

Notes:
Prodrugs used as antiviral agents
Same mechanisms of action as AZT
Used for herpes () simplex and shingles
1

Aciclovir (AVORAX) Chain Terminator

40

2/10/2015

7.4. DRUGS ACTING ON DNA


4.5 Chain terminators
a) Normal replication
C

DNA polymerase

DNA
template

Free OH

A
A

P
3'

OH

Growing
chain

DNA
template

3'

OH

Growing
chain

7.4. DRUGS ACTING ON DNA


4.5 Chain terminators
b) Chain termination
C

G
C

Drug

DNA
template

No free OH

P
3'

OH

Growing
chain

Chain termination

Drug

DNA
template

Growing
chain

41

2/10/2015

7.5. DRUGS ACTING ON rRNA


- antibiotics (antibacterial agent derived from a natural source)
- binds rRNA or proteins of ribosomes, resulting in inhibition
of translation process in protein synthesis)

7.5. DRUGS ACTING ON rRNA


Antibiotics

NH

NH
H2N

NH

HN

NH2

H
OH

HO H

OH

OH H
HO
H

Me

H
N

Me

O2N

H
O

CH2OH

CHO
H

OH

Me

C
O

HN H

Chloramphenicol
(vs typhoid)

Me

Me

HO

H
H

H
OMe

O
C

Streptomycin

OH
H

OH
Me

Me

CHCl2

O
CH2OH
H MeHN

H
OH

H
NMe2

CH3
HO

Rifamycins
O

OH

H3C

CH3
HO

OH
NH2

Cl

HO

Me

H3C

Chlortetracycline
(Aureomycin)

CH3

CH3

CH3
O

CH3

H
NMe2

HO

OH

Me
Me H OH

OH

OH
H

OH

O
Me

Erythromycin

OMe

42

2/10/2015

Interaction of Rifamycins with RNA polymerase

(Campbell et al, Cell 2001, 104, 901)

7.4. DRUGS ACTING ON mRNA


Antisense Therapy
- design and synthesis of antisense molecules (oligonucleotides)
which will bind to specific regions of mRNA and prevent the mRNA
acting as a code for protein synthesis

43

2/10/2015

7.3. DRUGS ACTING ON mRNA


Antisense Therapy
Advantages
Same effect as an enzyme inhibitor or receptor antagonist
Highly specific where the oligonucleotide is 17 nucleotides or more
Smaller dose levels required compared to inhibitors or antagonists
Potentially less side effects
Disadvantages
Exposed sections of mRNA must be targeted
Instability and polarity of oligonucleotides (pharmacokinetics)
Short lifetime of oligonucleotides and poor absorption across cell membranes

7.3. DRUGS ACTING ON mRNA


Antisense Therapy

block translation
antisense
molecule

(oligonucleotide)
Protein synthesis

m-RNA

A G U C U A C G U U

antisense
molecule

G U A A U C A G A U G C A A A A G U
m-RNA

antisense duplex
- treat some genetic disease, i.e. muscular dystrophy ()
1

44

S-ar putea să vă placă și